James H. Kocsis, MD

Antidepressant Side Effects and Panic

April 26, 2017

Do depressed patients with comorbid panic disorder have antidepressant treatment side effect profiles that differ from those of patients without panic disorder? Check out this article to review the...

Stewart A. Shankman, Stephanie M. Gorka, Andrea C. Katz, et al

Original Research

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

January 27, 2016

Thilo Deckersbach, Andrew A. Nierenberg, Melvin G. McInnis, et al

Original Research

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

January 27, 2016

Andrew A. Nierenberg, Susan L. McElroy, Edward S. Friedman, et al

Commentary

Antidepressant Augmentation: Good News, Limitations, and Stumbling Blocks

April 22, 2015

James H. Kocsis

In Memoriam

In Memoriam: Andrew C. Leon, PhD, 1951-2012

April 15, 2012

James H. Kocsis

Commentary

Questions Raised by the Failure of a Trial of Short-Term Psychodynamic Therapy Versus Pharmacotherapy for Major Depressive Disorder

January 15, 2012

James H. Kocsis

Original Research

Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination

January 13, 2009

James H. Kocsis, Andrew C. Leon, John C. Markowitz, et al

Original Research

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

October 31, 2008

Alan J. Gelenberg, Michael E. Thase, Roger E. Meyer, et al

Letter to the Editor

Reply ro "Does Venlafaxine Maintenance Therapy Prevent Depresion Recurrences or Drug Discontinuation Reactions?"

May 11, 2008

Martin B. Keller, James H. Kocsis

Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

August 15, 2007

Martin B. Keller, Madhukar H. Trivedi, Michael E. Thase, et al

Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

July 16, 2007

James H. Kocsis, Michael E. Thase, Madhukar H. Trivedi, et al

Commentary

Commentary: The State of Knowledge of Chronic Depression

April 15, 2006

Alan J. Gelenberg, James H. Kocsis, James P. McCullough, Jr., et al

Antidepressant Side Effects and Panic

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

Antidepressant Augmentation: Good News, Limitations, and Stumbling Blocks

In Memoriam: Andrew C. Leon, PhD, 1951-2012

Questions Raised by the Failure of a Trial of Short-Term Psychodynamic Therapy Versus Pharmacotherapy for Major Depressive Disorder

Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

Reply ro "Does Venlafaxine Maintenance Therapy Prevent Depresion Recurrences or Drug Discontinuation Reactions?"

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

Commentary: The State of Knowledge of Chronic Depression

ELSEWHERE:

FOLLOW US:

James H. Kocsis, MD

Antidepressant Side Effects and Panic

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

Antidepressant Augmentation: Good News, Limitations, and Stumbling Blocks

In Memoriam: Andrew C. Leon, PhD, 1951-2012

Questions Raised by the Failure of a Trial of Short-Term Psychodynamic Therapy Versus Pharmacotherapy for Major Depressive Disorder

Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

Reply ro "Does Venlafaxine Maintenance Therapy Prevent Depresion Recurrences or Drug Discontinuation Reactions?"

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

Commentary: The State of Knowledge of Chronic Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles